We demonstrated that miR‐146a inhibits the pro‐inflammatory chemokines IL‐8, CXCL1, and CCL5, induces the production of IFN‐λ, and has the capacity to limit infection by RV‐A16 in HBECs. The gene discussed is CXCL1; the disease is infection.